X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
plerixafor (411) 411
index medicus (302) 302
humans (277) 277
hematology (239) 239
transplantation (192) 192
male (167) 167
female (160) 160
hematopoietic stem cell mobilization - methods (146) 146
stem cells (135) 135
mobilization (131) 131
chemotherapy (127) 127
colony-stimulating factor (126) 126
middle aged (120) 120
adult (119) 119
hematopoietic stem cells (119) 119
oncology (117) 117
g-csf (116) 116
immunology (106) 106
aged (101) 101
amd3100 (97) 97
multiple myeloma (96) 96
multiple-myeloma (92) 92
heterocyclic compounds - administration & dosage (90) 90
cxcr4 (83) 83
non-hodgkins-lymphoma (81) 81
plus g-csf (80) 80
transplantation, autologous (77) 77
cancer (76) 76
granulocyte colony-stimulating factor - administration & dosage (74) 74
multiple myeloma - therapy (74) 74
granulocyte colony-stimulating factor (68) 68
animals (67) 67
progenitor cells (66) 66
hematopoietic stem cell transplantation (64) 64
stem cell mobilization (64) 64
receptors, cxcr4 - antagonists & inhibitors (63) 63
care and treatment (61) 61
heterocyclic compounds - therapeutic use (61) 61
lymphoma (59) 59
bone-marrow (54) 54
hematopoietic stem cell mobilization (54) 54
analysis (53) 53
heterocyclic compounds - pharmacology (53) 53
research (52) 52
treatment outcome (52) 52
article (51) 51
bone marrow (51) 51
hematology, oncology and palliative medicine (49) 49
lymphomas (49) 49
autologous transplantation (45) 45
retrospective studies (45) 45
granulocyte colony-stimulating factor - therapeutic use (44) 44
hematopoietic stem cell transplantation - methods (44) 44
medicine, research & experimental (42) 42
peripheral-blood (41) 41
adolescent (40) 40
health aspects (40) 40
blood (39) 39
collection (39) 39
lymphoma, non-hodgkin - therapy (39) 39
young adult (39) 39
hematopoietic stem cells - drug effects (36) 36
heterocyclic compounds - adverse effects (35) 35
cxcr4 antagonist (34) 34
cyclophosphamide (34) 34
hematopoietic stem (34) 34
hematopoietic stem cells - cytology (34) 34
mice (34) 34
apheresis (33) 33
autografts (33) 33
child (32) 32
hematopoietic progenitor cells (32) 32
cxcr4 antagonist plerixafor (31) 31
rapid mobilization (31) 31
receptors, cxcr4 - metabolism (31) 31
bone-marrow-transplantation (30) 30
high-dose chemotherapy (30) 30
cell biology (29) 29
chemokine receptor cxcr4 (29) 29
therapy (29) 29
autologous stem cell transplantation (28) 28
granulocyte colony-stimulating factor - pharmacology (28) 28
leukemia (27) 27
peripheral blood stem cell transplantation (27) 27
antigens, cd34 - metabolism (26) 26
pharmacology & pharmacy (26) 26
blood progenitor cells (25) 25
expression (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (23) 23
cxcl12 (23) 23
engraftment (23) 23
macrophage colony stimulating factor (23) 23
multiple-myeloma patients (23) 23
neutropenia (23) 23
patients (23) 23
children (22) 22
cxcr4 protein (22) 22
multiple myeloma - drug therapy (22) 22
myeloma (22) 22
stem cell transplantation (22) 22
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (456) 456
French (5) 5
Russian (4) 4
Polish (3) 3
Spanish (3) 3
Czech (1) 1
German (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Medical Hypotheses, ISSN 0306-9877, 09/2018, Volume 118, pp. 68 - 73
Death by , the leading cause of malaria, is going to remain a major obstacle among the infectious diseases. Plasmepsin aspartic proteases are key proteins in... 
Hemoglobin | Plasmepsin | Plerixafor | Malaria | Heme | Macrocycle
Journal Article
Journal Article
Bone Marrow Transplantation, ISSN 0268-3369, 04/2017, Volume 52, Issue 4, pp. 561 - 566
In an otherwise eligible patient with relapsed lymphoma, inadequate mobilization of peripheral blood stem cells is a limiting factor to proceeding with an... 
plerixafor | chemomobilization | mobilization | stem cell
Journal Article
European Journal of Immunology, ISSN 0014-2980, 05/2016, Volume 46, Issue 5, pp. 1271 - 1278
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 02/2012, Volume 18, Issue 2, pp. 241 - 249
We evaluated the safety and efficacy of plerixafor, subsequent to disease-specific chemotherapy followed by granulocyte-colony stimulating factor (G-CSF), in... 
PBSC mobilization | Plerixafor | Poor mobilizers | Autologous stem cell transplantation
Journal Article
American Journal of Physiology - Regulatory Integrative and Comparative Physiology, ISSN 0363-6119, 08/2018, Volume 315, Issue 2, pp. R218 - R229
Journal Article
Expert Opinion on Orphan Drugs, ISSN 2167-8707, 10/2017, Volume 5, Issue 10, pp. 813 - 825
Introduction: WHIM syndrome is a rare combined primary immunodeficiency disorder caused by autosomal dominant gain-of-function mutations in the chemokine... 
CXCR4 | WHIM syndrome | X4P-001/AMD11070 | myelokathexis | G-CSF | plerixafor/AMD3100 | MYELOKATHEXIS SYNDROME | COLONY-STIMULATING FACTOR | CHEMOKINE RECEPTOR CXCR4 | BONE-MARROW | HUMAN-PAPILLOMAVIRUS | CXCR4 ANTAGONIST PLERIXAFOR | MEMORY B-CELLS | PROTEIN-COUPLED RECEPTOR | HIV-1 ENTRY | PHARMACOLOGY & PHARMACY | STEM-CELL TRANSPLANTATION | plerixafor | X4P-001 | AMD3100 | AMD11070
Journal Article
Leukemia Research, ISSN 0145-2126, 10/2019, Volume 85, p. 106215
The stem cell mobilization agent plerixafor significantly improves CD34 stem cell procurement in patients with multiple myeloma undergoing autologous stem cell... 
Stem cell mobilization | Plerixafor | Cost analysis | Outcomes | Multiple myeloma
Journal Article
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, ISSN 1083-8791, 6/2018, Volume 24, Issue 6, pp. 1187 - 1195
The purpose of this report is to analyze long-term clinical outcomes of patients exposed to plerixafor plus granulocyte colony-stimulating factor (G-CSF) for... 
stem cell mobilization | plerixafor | multiple myeloma | non-hodgkin’s lymphoma | long-term follow-up
Journal Article
Blood, ISSN 0006-4971, 11/2016, Volume 128, Issue 20, pp. 2378 - 2380
Journal Article
Medicina Clinica, ISSN 0025-7753, 09/2016, Volume 147, Issue 5, pp. 223.e1 - 223.e7
Background and objective Poor mobilization of peripheral blood stem cells (CD34 cells) from bone marrow is a frequent reason for not reaching the autologous... 
Plerixafor | Myeloma | Pre-emptive | Lymphoma | Autologous stem cell transplantation
Journal Article